Viyash Scientific Approves Financial Results, ESOP Allotment, Vietnam Subsidiary

Viyash Scientific Ltd's Board of Directors met on August 11, 2026, approving the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the auditor's limited review report. The Board also approved the allotment of 10,30,775 equity shares under the ESOP Scheme 2026, increasing the company's paid-up capital. Additionally, the company will incorporate a wholly-owned subsidiary in Vietnam and invest up to ₹400.02 crore in its subsidiary Alivira Animal Health Limited (AAHL) through a rights issue to strengthen its capital structure.